propafenone has been researched along with dronedarone in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Eckert, L; Freemantle, N; Lafuente-Lafuente, C; Mitchell, S; Reynolds, M | 1 |
| Kong, DF; Piccini, JP | 1 |
| Byeon, K; Chun, KJ; Im, SI; Kim, JS; On, YK; Park, KM; Park, SJ | 1 |
| Al-Khatib, SM; Allen LaPointe, NM; Dai, D; Peterson, ED; Piccini, JP; Thomas, L | 1 |
| Dai, W; Gandhi, S; Juhaeri, J; Kechemir, H; Lin, S; Tcherny-Lessenot, S; Wang, Y; Wu, C | 1 |
| Chen, CY; Chiou, WR; Chuang, JY; Huang, CC; Kuo, JY; Lee, YH; Liao, FC; Lin, PL; Liu, LY; Su, MI; Tsai, CT; Wu, YJ | 1 |
| Apicella, C; Fabritz, L; Fobian, D; Gupta, S; Holmes, AP; Kabir, SN; Kirchhof, P; Kuhlmann, SM; O'Reilly, M; O'Shea, C; Pavlovic, D; Reyat, JS; Saxena, P; Smith, GL; Syeda, F; Workman, AJ | 1 |
| Chang, SH; Chen, SW; Huang, CH; Huang, YC; Huang, YT; Hung, KC; Kuo, CF; Tu, HT; Wang, CL; Wu, VC | 1 |
2 review(s) available for propafenone and dronedarone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Randomized Controlled Trials as Topic; Sotalol; Treatment Outcome | 2011 |
1 trial(s) available for propafenone and dronedarone
| Article | Year |
|---|---|
Efficacy of dronedarone versus propafenone in the maintenance of sinus rhythm in patients with atrial fibrillation after electrical cardioversion.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Dronedarone; Electric Countershock; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Propafenone; Recurrence; Time Factors | 2014 |
7 other study(ies) available for propafenone and dronedarone
| Article | Year |
|---|---|
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Mixed treatment comparisons for atrial fibrillation: evidence network or bewildering entanglement?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Evidence-Based Medicine; Flecainide; Humans; Propafenone; Sotalol; Treatment Outcome | 2011 |
Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Databases, Factual; Dronedarone; Drug Substitution; Female; Flecainide; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Propafenone; Sotalol | 2015 |
Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Databases, Factual; Dronedarone; Female; Flecainide; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Propafenone; Retrospective Studies; Sotalol | 2018 |
Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Diseases; Dronedarone; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Propafenone; Retrospective Studies; Rivaroxaban; Taiwan | 2021 |
Atrial resting membrane potential confers sodium current sensitivity to propafenone, flecainide and dronedarone.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dronedarone; Female; Flecainide; Heart Atria; Male; Membrane Potentials; Mice; Propafenone; Sodium; Voltage-Gated Sodium Channel Blockers | 2021 |
Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dronedarone; Humans; Ischemic Stroke; Propafenone; Stroke | 2023 |